why choose us

First received: September 13, 2022

Clinical Trial: Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Severe Peripheral Nerve Injury (PNI)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Peripheral Nerve Injury

Study Type: INTERVENTIONAL


Official Title: Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Severe Peripheral Nerve Injury (PNI)

Brief Summary: The primary purpose of this research study is to evaluate the safety and possible harms of injecting one's own Schwann cells along with nerve auto-graft after a severe injury to a major nerve has occurred.

Read more